Topical and Conventional Systemic Treatments in Atopic Dermatitis: Have They Gone Out of Fashion?

Atopic dermatitis is a Th2 disease, due to relapse of IL-4 and IL-13 by Th2 cells. Despite the approval by FDA of dupilumab, the first monoclonal antibody for the severe forms, traditional drugs remain a milestone for the treatment of this dermatosis. Dermatologists need a good knowledge of all ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Calabrese, Giulia, Licata, Gaetano, Gambardella, Alessio, De Rosa, Alina, Alfano, Roberto, Argenziano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824598/
https://www.ncbi.nlm.nih.gov/pubmed/35223191
http://dx.doi.org/10.5826/dpc.1201a155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824598/
https://www.ncbi.nlm.nih.gov/pubmed/35223191
http://dx.doi.org/10.5826/dpc.1201a155

Ejemplares similares